Eurofins Scientific (ERFSF) News Today $49.49 +3.12 (+6.73%) As of 01/17/2025 01:55 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Eurofins Scientific (OTCMKTS:ERFSF) Rating Lowered to "Hold" at Berenberg BankBerenberg Bank downgraded Eurofins Scientific from a "strong-buy" rating to a "hold" rating in a research note on Wednesday.January 18 at 6:29 AM | marketbeat.comBerenberg Bank downgrades Eurofins Scientific (0MV5) to a HoldJanuary 16, 2025 | markets.businessinsider.comEurofins Scientific: Strong Cash Flows Will Fund M&A To Boost EBITDA GrowthJanuary 9, 2025 | seekingalpha.comEurofins Scientific (OTCMKTS:ERFSF) Share Price Passes Above 50 Day Moving Average - Here's What HappenedEurofins Scientific (OTCMKTS:ERFSF) Stock Passes Above Fifty Day Moving Average - Time to Sell?December 25, 2024 | marketbeat.comEurofins Scientific SE (OTCMKTS:ERFSF) Short Interest UpdateEurofins Scientific SE (OTCMKTS:ERFSF - Get Free Report) was the recipient of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 300,000 shares, an increase of 15.6% from the November 15th total of 259,500 shares. Based on an average trading volume of 16,500 shares, the short-interest ratio is currently 18.2 days.December 16, 2024 | marketbeat.comEurofins Scientific (OTCMKTS:ERFSF) Shares Pass Below Fifty Day Moving Average - Here's What HappenedEurofins Scientific (OTCMKTS:ERFSF) Stock Passes Below 50 Day Moving Average - Here's WhyNovember 7, 2024 | marketbeat.comEurofins Confirms Profitability and Cash Flow Objectives for 2024 Leading to Higher Profit Margins in Spite of the Impact of the Post-COVID Reset of BioPharma PipelinesOctober 22, 2024 | businesswire.comEurofins Shares Slide After Revenue Target CutOctober 22, 2024 | marketwatch.comEurofins Announces Results of Cash Audit Confirming Its FY 2023 Cash Balance and the High Integrity of Its Systems and Controls and Refutes Muddy Waters’ Allegations ...October 22, 2024 | businesswire.comEurofins says independent audit refutes short seller's allegationsOctober 22, 2024 | msn.comEurofins Discovery Extends AI-powered Integrated Drug Discovery CollaborationOctober 10, 2024 | tmcnet.comBerenberg Bank Reaffirms Their Buy Rating on Eurofins Scientific (0MV5)October 7, 2024 | markets.businessinsider.comEurofins testing labs buys building to occupy in Rancho CordovaOctober 1, 2024 | bizjournals.comEurofins Scientific SE (ERFSF) Q2 2024 Earnings Call TranscriptJuly 25, 2024 | seekingalpha.comEurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical LaboratoryMay 29, 2024 | finance.yahoo.comEurofins Scientific SE: Purchases of Own Shares From the 20th of May 2024 to the 24th of May 2024May 27, 2024 | finance.yahoo.comEurofins: Purchases of own shares from the 13th of May 2024 to the 17th of May 2024May 21, 2024 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2024May 15, 2024 | finance.yahoo.comThe Eurofins Network Expands Battery Testing Services, Supporting Client Acceleration of Battery InnovationMay 13, 2024 | finance.yahoo.comFDA Experts Weigh In On Incannex's CannQuit-O With Feedback On CBD As Treatment For Opioid Use DisorderMay 7, 2024 | msn.comEurofins Scientific SE: Purchases of Own Shares From the 29th of April 2024 to the 3rd of May 2024May 6, 2024 | finance.yahoo.comEurofins Scientific SE: Purchases of Own Shares From the 25th to the 26th of April 2024April 29, 2024 | finance.yahoo.comEurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its ObjectivesApril 24, 2024 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2024April 5, 2024 | finance.yahoo.comThe Eurofins Network Expands Its Offering in Renal and Transplant Testing in the United States With the Acquisition of Ascend Clinical LLCApril 3, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares from the 18th to the 22th of March 2024March 25, 2024 | finance.yahoo.comEurofins: Convening Notice of the Shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting of the Company Valid as an Information Notice for the BondholdersMarch 25, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares From the 11th to the 15th of March 2024March 18, 2024 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 29 February 2024March 12, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares From the 5th to the 8th of March 2024March 11, 2024 | finance.yahoo.comEUROFINS SCIENT (ERFSF) Upgraded to Buy: What Does It Mean for the Stock?March 8, 2024 | msn.comEurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary DatasetsFebruary 29, 2024 | finance.yahoo.comEurofins Scientific reports FY resultsFebruary 27, 2024 | msn.comEurofins Delivers Strong Margin Improvement and Cash Generation in H2 2023 and Annual Results in Line With Its 2023 Objectives. Remains Confident to Achieve Its 2027 Objectives.February 27, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares from the 12th to the 14th of February 2024February 19, 2024 | finance.yahoo.comEurofins Scientific SE: Purchases of Own Shares from the 5th to the 9th of February 2024February 12, 2024 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 January 2024February 7, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares From the 29th of January to the 2nd of February 2024February 5, 2024 | finance.yahoo.comEurofins Environment Testing in Sacramento, CA in Partnership with EPA Region 10 and EPA’s Office of Water Published Draft Method 1634, an Analytical Procedure to Test for 6PPD-Quinone in Surface and StormwaterFebruary 2, 2024 | finance.yahoo.comEurofins: Purchases of Own Shares From the 22th of January to the 26th of January 2024January 29, 2024 | finance.yahoo.comGiverny Capital Asset Management Q4 2023 LetterJanuary 28, 2024 | seekingalpha.comEurofins: Purchases of Own Shares From the 15th of January to the 19 of January 2024January 22, 2024 | finance.yahoo.comEurofins Scientific SE (0MV5)January 18, 2024 | uk.investing.comEurofins: Purchases of Own Shares From the 12th of January 2024January 15, 2024 | finance.yahoo.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 December 2023January 4, 2024 | finance.yahoo.comTracking Ruane, Cunniff & Goldfarb's Portfolio - Q3 2023 UpdateDecember 20, 2023 | seekingalpha.comEurofins Reinforces Its Agroscience Contract Research Services by Acquiring SGS’ Crop Science OperationsDecember 18, 2023 | finance.yahoo.comSGS SA: A Defensive, High-Quality Business Finally Trading At A Fair Price Once AgainDecember 14, 2023 | seekingalpha.comEurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2023December 7, 2023 | finance.yahoo.comEurofins Scientific Announces the Acquisition of Labor 3, Further Expanding Its Offering to the Food and Feed Market in Brazil and the Presence of Eurofins Laboratories in Latin AmericaNovember 16, 2023 | finance.yahoo.com Get Eurofins Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for ERFSF and its competitors with MarketBeat's FREE daily newsletter. Email Address ERFSF Media Mentions By Week ERFSF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ERFSF News Sentiment▼-0.750.48▲Average Medical News Sentiment ERFSF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ERFSF Articles This Week▼30▲ERFSF Articles Average Week Get Eurofins Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for ERFSF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DKILY News CHCJY News SWRAY News FJTSY News HENKY News AMADY News DSCSY News ASHTY News KHNGY News SUHJY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ERFSF) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eurofins Scientific SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Eurofins Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ERFSF Stock Alerts